Therapeutic and diagnostic role of electrical devices in acute heart failure
暂无分享,去创建一个
[1] Jacques Victor,et al. Programming Optimal Atrioventricular Delay in Dual Chamber Pacing Using Peak Endocardial Acceleration: Comparison with a Standard Echocardiographic Procedure , 2003, Pacing and clinical electrophysiology : PACE.
[2] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[3] A. Rickards,et al. An Implantable Intracardiac Accelerometer for Monitoring Myocardial Contractility , 1996, Pacing and clinical electrophysiology : PACE.
[4] Lars Rydén,et al. Continous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure , 2002 .
[5] Thomas Lavergne,et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.
[6] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[7] Michael O. Sweeney,et al. Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.
[8] Wojciech Zareba,et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.
[9] Philip Adamson,et al. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. , 2002, Journal of cardiac failure.
[10] N. Freemantle,et al. Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction — a systematic review and meta‐analysis , 2006, European journal of heart failure.
[11] R. Prescott,et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). , 1998, Circulation.
[12] B. Tedner,et al. Influence of furosemide and body posture on transthoracic electrical impedance in AMI. , 1986, Chest.
[13] M. Fisher,et al. Effects of exercise training on peak performance and quality of life in congestive heart failure patients. , 1999, Journal of cardiac failure.
[14] J. Hansen,et al. Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. , 1994, European heart journal.
[15] Milton Packer,et al. Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.
[16] G. Fonarow,et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. , 2000, American heart journal.
[17] Hassan Mansour,et al. Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices. , 2005, The American journal of cardiology.
[18] J. Cohn,et al. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. , 2001, The New England journal of medicine.
[19] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[20] N Freemantle,et al. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.
[21] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[22] Frieder Braunschweig,et al. Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] J. Cleland,et al. Is the prognosis of heart failure improving? , 1999, Journal of the American College of Cardiology.
[24] L. Rydén,et al. Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. , 1998, European heart journal.
[25] F. Braunschweig,et al. Continuous Hemodynamic Monitoring in Heart Failure , 2002, Journal of cardiovascular electrophysiology.
[26] B. Wilkoff,et al. Biventricular pacing for heart failure patients on inotropic support: a review of 38 consecutive cases. , 2006, Texas Heart Institute journal.
[27] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[28] M. Bristow,et al. The role of third‐generation beta‐blocking agents in chronic heart failure , 1998, Clinical cardiology.
[29] C. H. Chen,et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. , 1999, Circulation.
[30] C. O’loughlin,et al. Clinical deterioration in established heart failure: What is the value of BNP and weight gain in aiding diagnosis? , 2005, European journal of heart failure.
[31] M. Luu,et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy , 1990 .
[32] Monica R. Shah,et al. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness The ESCAPE Trial , 2005 .
[33] D. Delurgio,et al. Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.
[34] D. Theuns,et al. Home monitoring in ICD therapy: future perspectives. , 2003, Europace.
[35] L. Stevenson,et al. Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. , 1989, The American journal of cardiology.
[36] Eric Fain,et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.
[37] C. O'connor,et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. , 2005, Journal of the American College of Cardiology.
[38] L. Rydén,et al. Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. , 2002, European heart journal.
[39] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[40] T. Rector,et al. Maximal exercise tolerance as a therapeutic end point in heart failure--are we relying on the right measure? , 1994, The American journal of cardiology.
[41] M. L. La Rovere,et al. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. , 2005, Journal of the American College of Cardiology.
[42] J. Parker,et al. Cardiac resynchronisation therapy: an option for inotrope‐supported patients with end‐stage heart failure? , 2005 .
[43] M. Luu,et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. , 1990, The American journal of cardiology.
[44] D. Weiss,et al. Remote Monitoring of Implantable Cardioverter Defibrillators: , 2004, Pacing and clinical electrophysiology : PACE.
[45] C. Lau,et al. Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization , 2005, Circulation.
[46] Catherine Klersy,et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.
[47] A. Battler,et al. Urgent Cardiac Resynchronization Therapy in Patients with Decompensated Chronic Heart Failure Receiving Inotropic Therapy , 2006, Cardiology.
[48] D. Bonaduce,et al. Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure. , 1999, American heart journal.
[49] R. Canby,et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.
[50] L. Baker,et al. Noninvasive measurement of intrathoracic fluids. , 1974, Chest.
[51] K. Kuck,et al. Focal Atrial Tachycardia Originating from the Musculature of the Coronary Sinus , 2002, Journal of cardiovascular electrophysiology.
[52] William T. Abraham,et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness , 2005 .
[53] L. Rydén,et al. Reduction of hospital days by biventricular pacing , 2000, European journal of heart failure.
[54] W. Abraham,et al. Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device , 2004, Circulation.
[55] J. Daubert,et al. Effects of cardiac resynchronization therapy on heart rate variability in patients with chronic systolic heart failure and intraventricular conduction delay. , 2003, The American journal of cardiology.
[56] M. Haïssaguerre,et al. Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study , 2002, Heart.
[57] G. Fonarow,et al. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. , 2003, Reviews in cardiovascular medicine.
[58] R. Frye. Chronic congestive heart failure. Eight steps in management. , 1981, Postgraduate medicine.
[59] J. O’Connell,et al. The economic burden of heart failure , 2000, Clinical cardiology.
[60] D. Behar,et al. Long‐term prognosis of acute pulmonary oedema — an ominous outcome , 2000, European journal of heart failure.
[61] L. Rydén,et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. , 2003, Journal of the American College of Cardiology.
[62] M. Santini,et al. THE VALUE OF PERMANENT FOLLOW-UP OF IMPLANTABLE PACEMAKERS - FIRST RESULTS OF AN EUROPEAN TRIAL , 2002, Biomedizinische Technik. Biomedical engineering.
[63] A. Fitzpatrick,et al. Biventricular pacing in a patient with ventilatory and inotropic dependant heart failure following coronary artery by-pass surgery. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[64] Andrew P. Kramer,et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. , 1999, Circulation.
[65] A J Cowley,et al. Relation of daily activity levels in patients with chronic heart failure to long-term prognosis. , 1997, The American journal of cardiology.
[66] David O. Martin,et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.
[67] J N Sahalos,et al. The electrical impedance of the human thorax as a guide in evaluation of intrathoracic fluid volume. , 1986, Physics in medicine and biology.
[68] S Adler,et al. Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study. , 2001, European heart journal.
[69] Bristow. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) : Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure , 2004 .
[70] W. Klein,et al. Continuous hemodynamic monitoring in pulmonary hypertensive patients treated with inhaled iloprost. , 2003, Chest.
[71] B. Kjellström,et al. Trans-telephonic monitoring of continuous haemodynamic measurements in heart failure patients , 2005, Journal of telemedicine and telecare.
[72] Karl Swedberg,et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. , 2005, European heart journal.
[73] Eric Boersma,et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. , 2006, European heart journal.
[74] Å. Hjalmarson. Significance of reduction in heart rate in cardiovascular disease. , 1998, Clinical cardiology.
[75] L. Stevenson,et al. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.
[76] The evolving challenge of chronic heart failure management: a call for a new curriculum for training heart failure specialists. , 2004, Journal of the American College of Cardiology.
[77] L. Waspe,et al. Accuracy and Clinical Utility of Transtelephonic Pacemaker Follow‐Up , 1995, Pacing and clinical electrophysiology : PACE.
[78] F. Gadler,et al. Optimization of Cardiac Resynchronization Therapy by Continuous Hemodynamic Monitoring: , 2004, Journal of cardiovascular electrophysiology.